T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
Holders of 5% or more of TTOO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of T2 Biosystems, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| JSAF Holdings, LLC | 13G/A | 5.30%1.50M shares | – | Nov 6, 20242 filings | Feb 13, 2025 | SEC |
| Safier Jacob | 13G/A | 5.30%1.50M shares | – | Mar 11, 20244 filings | Feb 13, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
24 Schedule 13D and 13G filings on T2 Biosystems, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 20259:24 PM ET | JSAF Holdings, LLCand 1 other | 13G/A | 5.30%1.50M shares | – | Dec 31, 2024 | SEC |
| Feb 13, 20259:22 PM ET | Safier Jacoband 1 other | 13G/A | 5.30%1.50M shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Nov 6, 2024 | JSAF Holdings, LLC | 13GOld format | – | New | – | SEC |
| Nov 6, 2024 | Safier Jacob | 13GOld format | – | – | – | SEC |
| Aug 15, 2024 | New Dimensions Trading | 13G/AOld format | – | – | – | SEC |
| Aug 15, 2024 | Safier Jacob | 13G/AOld format | – | – | – | SEC |
| May 13, 2024 | CR Group L.P. | 13D/AOld format | – | – | – | SEC |
| May 7, 2024 | CR Group L.P. | 13D/AOld format | – | – | – | SEC |
| Apr 19, 2024 | CR Group L.P. | 13DOld format | – | – | – | SEC |
| Mar 11, 2024 | Safier Jacob | 13GOld format | – | New | – | SEC |
| Mar 11, 2024 | New Dimensions Trading | 13GOld format | – | New | – | SEC |
| Feb 13, 2024 | Lind Global Fund II LP | 13G/AOld format | – | – | – | SEC |
| Jul 31, 2023 | Gsa Capital Partners LLP | 13GOld format | – | – | – | SEC |
| Jul 13, 2023 | CR Group L.P. | 13GOld format | – | New | – | SEC |
| Jun 30, 2023 | Gsa Capital Partners LLP | 13GOld format | – | – | – | SEC |
| Jun 23, 2023 | Carrick Jason | 13GOld format | – | New | – | SEC |
| Jun 22, 2023 | Markey John | 13GOld format | – | – | – | SEC |
| Jun 21, 2023 | Gsa Capital Partners LLP | 13GOld format | – | New | – | SEC |
| Jun 16, 2023 | Markey John | 13GOld format | – | – | – | SEC |
| Jun 14, 2023 | Markey John | 13GOld format | – | – | – | SEC |
| Jun 12, 2023 | Markey John | 13GOld format | – | New | – | SEC |
| Feb 21, 2023 | Lind Global Fund II LP | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Goldman Sachs & Co. LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell T2 Biosystems, Inc. shares.
No Form 144 notices for T2 Biosystems, Inc. are on file.